Cause of death, by non-communicable diseases, ages 15-59 in Kyrgyzstan
Kyrgyzstan: Cause of death, by non-communicable diseases, ages 15-59 was 52.4% in 2021. ▼ Falling
Cause of death, by non-communicable diseases, ages 15-59 in Kyrgyzstan, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total deaths ages 15-59.
Analysis
Kyrgyzstan recorded 52.4% for cause of death, by non-communicable diseases, ages 15-59 in 2021. That is the lowest value across all 6 years on record.
That represents a change of down 7.5% on the previous year and down 23.5% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 15-59 in Kyrgyzstan peaked at 74.7% in 2019 and was at its lowest, 52.4%, in 2021.
That places Kyrgyzstan 97th out of 185 countries with data for 2021, putting it in the middle of the range.
Cause of death, by non-communicable diseases, ages 15-59 in Kyrgyzstan, year by year
| Year | % of total deaths ages 15-59 | Change |
|---|---|---|
| 2000 | 64.9% | — |
| 2010 | 68.4% | +5.4% |
| 2015 | 73.7% | +7.8% |
| 2019 | 74.7% | +1.3% |
| 2020 | 56.6% | -24.2% |
| 2021 | 52.4% | -7.5% |
Kyrgyzstan compared with similar countries
- Kyrgyzstan's 52.4% is above the median for lower middle income countries, which is 46.3%, 1.1× the median. (47 countries reporting)
- Kyrgyzstan's 52.4% is below the median for Europe & Central Asia, which is 68.4%, 77% of the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 64.9% | 64.9% | 64.9% | 1 |
| 2010s | 72.3% | 68.4% | 74.7% | 3 |
| 2020s | 54.5% | 52.4% | 56.6% | 2 |
Countries ranked near Kyrgyzstan
More health data for Kyrgyzstan
- Un projection of annual infant deaths, annual growth rate -1.77 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6971 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 938.9 deaths per 1,000 people (2090)
- Number of infants who die before age 1 278 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2023)
- Population ages 00-04, female, annual growth rate -1.95 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0501 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.01 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 15-59 in Kyrgyzstan?
- Cause of death, by non-communicable diseases, ages 15-59 in Kyrgyzstan was 52.4% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 15-59 recorded in Kyrgyzstan?
- The highest recorded value was 74.7% in 2019.
- What is the lowest cause of death, by non-communicable diseases, ages 15-59 recorded in Kyrgyzstan?
- The lowest recorded value was 52.4% in 2021.
- How does Kyrgyzstan rank for cause of death, by non-communicable diseases, ages 15-59?
- Kyrgyzstan ranks 97th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 15-59 rising or falling in Kyrgyzstan?
- Over the last ten years it is down 23.5%. The long-run trend across the full record is falling.
- Where does this Kyrgyzstan data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.